Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Sep 3;74(5):955–967. doi: 10.1007/s00280-014-2569-7

Table 4.

Maintenance phase toxicity (number of occurrences during cycle 1 of perifosinea)

Toxicity Dose level 1
Dose level II
Dose level III
Dose level IV
Dose level V
(N = 3)
(N = 3)
(N = 3)
(N = 3)
(N = 3)
Gr1 Gr2 Gr3 Gr1 Gr2 Gr3 Gr1 Gr2 Gr3 Gr4 Gr1 Gr2 Gr3 Gr1 Gr2 Gr3
Albumin 3 3 1 1
Alk Phos 1
Anemia 1 1 2 2 5 4 1
Anorexia 1 1 2 1
Arthralgia 2 1
Cough 1
Creatinine 1
Dehydration 1 1
Diarrhea 1 1 1 1
Dizziness 2
Dyspepsia 1 2
Dyspnea 1
Fatigue 1 1 1
Fever 1
Headache 2 1
Hyperglycemia 1 1 1 1 3 6 2
Hot flash 1
Hypoxia 1 1
Infection 2 1
Lymphopenia 2
Myalgia 1
Nausea 1 4 2 2 1
Neutropenia 1 1 1
Stomatitis 1
SVT 1
Taste 1
Transaminase 3
Tumor flare 1
Vision 1
Vomiting 3 1 2 1
a

Toxicities from all arms (a–c) have been combined. Anemia, lymphopenia not included.